25 XP   0   0   10

Dyne Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Dyne Therapeutics Inc together

PenkeI guess you are interested in Dyne Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dyne Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dyne Therapeutics Inc

I send you an email if I find something interesting about Dyne Therapeutics Inc.

Quick analysis of Dyne Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Dyne Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
38.2%

What is your share worth?

Current worth
$1.11
Expected worth in 1 year
$-0.85
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$-1.97
Return On Investment
-7.9%

For what price can you sell your share?

Current Price per Share
$24.98
Expected price per share
$15.63 - $30.27
How sure are you?
50%

1. Valuation of Dyne Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$24.98

Intrinsic Value Per Share

$-22.49 - $20.99

Total Value Per Share

$-21.37 - $22.10

2. Growth of Dyne Therapeutics Inc (5 min.)




Is Dyne Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$91.2m$281.4m-$108.3m-62.6%

How much money is Dyne Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$58.5m-$41.3m-$17.2m-29.5%
Net Profit Margin-439.8%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Dyne Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#383 / 1010

Most Revenue
#502 / 1010

Most Profit
#908 / 1010

Most Efficient
#721 / 1010

What can you expect buying and holding a share of Dyne Therapeutics Inc? (5 min.)

Welcome investor! Dyne Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Dyne Therapeutics Inc.

What can you expect buying and holding a share of Dyne Therapeutics Inc?

First you should know what it really means to hold a share of Dyne Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Dyne Therapeutics Inc is $24.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dyne Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dyne Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.11. Based on the TTM, the Book Value Change Per Share is $-0.49 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dyne Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.81-3.3%-0.78-3.1%-0.56-2.3%-0.45-1.8%-0.59-2.4%
Usd Book Value Change Per Share-0.74-3.0%-0.49-2.0%-0.35-1.4%-0.59-2.4%-0.62-2.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.020.1%
Usd Total Gains Per Share-0.74-3.0%-0.49-2.0%-0.35-1.4%-0.59-2.4%-0.60-2.4%
Usd Price Per Share13.30-11.26-10.20-10.65-5.64-
Price to Earnings Ratio-4.09--3.58--4.72--6.53--3.46-
Price-to-Total Gains Ratio-17.94--37.04-74.59--1.91--1.91-
Price to Book Ratio11.94-6.28-3.06-3.29-1.74-
Price-to-Total Gains Ratio-17.94--37.04-74.59--1.91--1.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share24.98
Number of shares40
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.49-0.59
Usd Total Gains Per Share-0.49-0.59
Gains per Quarter (40 shares)-19.65-23.60
Gains per Year (40 shares)-78.61-94.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-79-890-94-104
20-157-1680-189-198
30-236-2470-283-292
40-314-3260-378-386
50-393-4050-472-480
60-472-4840-566-574
70-550-5630-661-668
80-629-6420-755-762
90-708-7210-850-856
100-786-8000-944-950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.018.00.00.0%2.032.00.05.9%8.053.00.013.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.012.01.027.8%10.023.01.029.4%17.043.01.027.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%13.00.021.038.2%13.00.048.021.3%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.012.01.027.8%10.023.01.029.4%17.043.01.027.9%

Fundamentals of Dyne Therapeutics Inc

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 06:26:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dyne Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dyne Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -1,759.2% means that $-17.59 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dyne Therapeutics Inc:

  • The MRQ is -1,759.2%. The company is making a huge loss. -2
  • The TTM is -439.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,759.2%TTM-439.8%-1,319.4%
TTM-439.8%YOY--439.8%
TTM-439.8%5Y-97.7%-342.1%
5Y-97.7%10Y-78.3%-19.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,759.2%-200.1%-1,559.1%
TTM-439.8%-216.8%-223.0%
YOY--288.3%+288.3%
5Y-97.7%-449.1%+351.4%
10Y-78.3%-605.5%+527.2%
1.1.2. Return on Assets

Shows how efficient Dyne Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • -40.4% Return on Assets means that Dyne Therapeutics Inc generated $-0.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dyne Therapeutics Inc:

  • The MRQ is -40.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.4%TTM-27.6%-12.8%
TTM-27.6%YOY-12.5%-15.0%
TTM-27.6%5Y-16.2%-11.3%
5Y-16.2%10Y-9.2%-7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.4%-13.3%-27.1%
TTM-27.6%-12.8%-14.8%
YOY-12.5%-11.7%-0.8%
5Y-16.2%-13.9%-2.3%
10Y-9.2%-15.7%+6.5%
1.1.3. Return on Equity

Shows how efficient Dyne Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • -73.0% Return on Equity means Dyne Therapeutics Inc generated $-0.73 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dyne Therapeutics Inc:

  • The MRQ is -73.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-73.0%TTM-40.4%-32.6%
TTM-40.4%YOY-14.9%-25.5%
TTM-40.4%5Y-20.6%-19.8%
5Y-20.6%10Y-14.7%-5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-73.0%-16.9%-56.1%
TTM-40.4%-16.1%-24.3%
YOY-14.9%-15.1%+0.2%
5Y-20.6%-19.3%-1.3%
10Y-14.7%-20.2%+5.5%

1.2. Operating Efficiency of Dyne Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dyne Therapeutics Inc is operating .

  • Measures how much profit Dyne Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -1,786.9% means the company generated $-17.87  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dyne Therapeutics Inc:

  • The MRQ is -1,786.9%. The company is operating very inefficient. -2
  • The TTM is -446.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,786.9%TTM-446.7%-1,340.2%
TTM-446.7%YOY--446.7%
TTM-446.7%5Y-99.3%-347.5%
5Y-99.3%10Y-62.5%-36.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,786.9%-296.2%-1,490.7%
TTM-446.7%-232.5%-214.2%
YOY--298.2%+298.2%
5Y-99.3%-492.1%+392.8%
10Y-62.5%-632.4%+569.9%
1.2.2. Operating Ratio

Measures how efficient Dyne Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 17.87 means that the operating costs are $17.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Dyne Therapeutics Inc:

  • The MRQ is 17.869. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.467. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ17.869TTM4.467+13.402
TTM4.467YOY-+4.467
TTM4.4675Y0.993+3.475
5Y0.99310Y1.482-0.489
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.8693.231+14.638
TTM4.4673.310+1.157
YOY-3.890-3.890
5Y0.9935.739-4.746
10Y1.4827.876-6.394

1.3. Liquidity of Dyne Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dyne Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.53 means the company has $2.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Dyne Therapeutics Inc:

  • The MRQ is 2.532. The company is able to pay all its short-term debts. +1
  • The TTM is 7.356. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.532TTM7.356-4.824
TTM7.356YOY11.660-4.304
TTM7.3565Y18.466-11.110
5Y18.46610Y10.957+7.509
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5323.890-1.358
TTM7.3564.173+3.183
YOY11.6605.344+6.316
5Y18.4666.126+12.340
10Y10.9576.448+4.509
1.3.2. Quick Ratio

Measures if Dyne Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 2.44 means the company can pay off $2.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dyne Therapeutics Inc:

  • The MRQ is 2.438. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.655. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.438TTM8.655-6.217
TTM8.655YOY16.522-7.867
TTM8.6555Y21.878-13.223
5Y21.87810Y12.443+9.435
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4383.514-1.076
TTM8.6553.998+4.657
YOY16.5225.380+11.142
5Y21.8786.105+15.773
10Y12.4436.404+6.039

1.4. Solvency of Dyne Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dyne Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dyne Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.45 means that Dyne Therapeutics Inc assets are financed with 44.7% credit (debt) and the remaining percentage (100% - 44.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dyne Therapeutics Inc:

  • The MRQ is 0.447. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.261. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.447TTM0.261+0.186
TTM0.261YOY0.158+0.104
TTM0.2615Y0.182+0.079
5Y0.18210Y0.451-0.268
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4470.339+0.108
TTM0.2610.336-0.075
YOY0.1580.271-0.113
5Y0.1820.366-0.184
10Y0.4510.389+0.062
1.4.2. Debt to Equity Ratio

Measures if Dyne Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 80.8% means that company has $0.81 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dyne Therapeutics Inc:

  • The MRQ is 0.808. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.392. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.808TTM0.392+0.417
TTM0.392YOY0.188+0.204
TTM0.3925Y0.465-0.074
5Y0.46510Y1.888-1.423
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8080.388+0.420
TTM0.3920.402-0.010
YOY0.1880.335-0.147
5Y0.4650.426+0.039
10Y1.8880.461+1.427

2. Market Valuation of Dyne Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dyne Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Dyne Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -4.09 means the investor is paying $-4.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dyne Therapeutics Inc:

  • The EOD is -7.681. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.089. Based on the earnings, the company is expensive. -2
  • The TTM is -3.582. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.681MRQ-4.089-3.591
MRQ-4.089TTM-3.582-0.508
TTM-3.582YOY-4.718+1.136
TTM-3.5825Y-6.533+2.951
5Y-6.53310Y-3.459-3.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.681-2.264-5.417
MRQ-4.089-2.629-1.460
TTM-3.582-2.680-0.902
YOY-4.718-4.145-0.573
5Y-6.533-6.257-0.276
10Y-3.459-6.254+2.795
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dyne Therapeutics Inc:

  • The EOD is -14.587. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.766. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.129. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.587MRQ-7.766-6.820
MRQ-7.766TTM-5.129-2.638
TTM-5.129YOY-5.563+0.435
TTM-5.1295Y-8.024+2.895
5Y-8.02410Y-4.248-3.776
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.587-2.973-11.614
MRQ-7.766-3.333-4.433
TTM-5.129-3.553-1.576
YOY-5.563-5.605+0.042
5Y-8.024-8.376+0.352
10Y-4.248-8.865+4.617
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dyne Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.94 means the investor is paying $11.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Dyne Therapeutics Inc:

  • The EOD is 22.426. Based on the equity, the company is expensive. -2
  • The MRQ is 11.940. Based on the equity, the company is expensive. -2
  • The TTM is 6.282. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD22.426MRQ11.940+10.486
MRQ11.940TTM6.282+5.658
TTM6.282YOY3.060+3.222
TTM6.2825Y3.291+2.991
5Y3.29110Y1.742+1.549
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.4261.896+20.530
MRQ11.9402.115+9.825
TTM6.2822.093+4.189
YOY3.0602.884+0.176
5Y3.2913.542-0.251
10Y1.7423.916-2.174
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Dyne Therapeutics Inc.

3.1. Institutions holding Dyne Therapeutics Inc

Institutions are holding 86.203% of the shares of Dyne Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FCPM III SERVICES BV7.480824.026613107961310790
2023-12-31Mpm Asset Management, LLC6.041332.3597495130300
2023-12-31BlackRock Inc4.62270.0013378868248171714.5667
2023-09-30Citadel Advisors Llc3.71120.0058304160633560312.4022
2023-12-31State Street Corporation2.85160.0015233714139849920.5556
2023-12-31Vanguard Group Inc2.84250.00072329641-34673-1.4665
2023-12-31Goldman Sachs Group Inc2.83260.0028232154481340253.934
2023-09-30VR Adviser, LLC2.65252.0505217391300
2023-12-31Vida Ventures Advisors, LLC2.531532.85172074787-145247-6.5426
2023-12-31Morgan Stanley - Brokerage Accounts2.46640.0024202139519136531776.1439
2023-12-31Deep Track Capital, LP2.44030.88832000000-403672-16.794
2023-12-31Franklin Resources Inc2.33510.011919138328760.0458
2023-12-31Logos Global Management LP2.29392.3341880000-300000-13.7615
2023-09-30BRAIDWELL LP2.22310.5159182197244410032.2309
2023-12-31Wasatch Advisors Inc.2.05530.12341684517-3285-0.1946
2023-12-31TCG Crossover Management, LLC2.01342.434165015000
2023-12-31Nantahala Capital Management, LLC1.56860.5114128557860241488.18
2023-12-31FMR Inc1.56520.0013128281243645251.5681
2023-12-31Artal Group S A1.48610.5385121796040287549.4274
2023-12-31Vivo Capital, LLC1.2631.1272103513600
Total 57.277199.788346943048+11073793+23.6%

3.2. Funds holding Dyne Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28SPDR® S&P Biotech ETF3.50091.07882869265362001.2778
2024-02-29Vanguard Total Stock Mkt Idx Inv2.55670.0036209543200
2024-03-28iShares Russell 2000 ETF1.76610.062814475026990.0483
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.00330.0217822261-796-0.0967
2024-02-29Candriam Eqs L Biotech C USD Cap0.94031.2613770624-58000-6.9996
2024-02-29Fidelity Growth Compy Commingled Pl O0.91740.02587519007890011.7236
2024-02-29Fidelity Select Pharmaceuticals Port0.91021.863974600000
2023-12-31Franklin US Small Cap Growth Equity0.89860.353373650000
2024-02-29Franklin Biotechnology Discv A(acc)USD0.88611.058472619000
2024-03-31Jennison Health Sciences Equity0.8081.0196622516622510
2024-02-29PGIM Jennison Health Sciences Z0.8080.991966225100
2024-02-29Franklin Small Cap Growth Adv0.74210.5642608200-128300-17.4202
2024-02-29Fidelity Growth Company Fund0.69970.02595735006290012.3188
2023-12-31Wasatch Ultra Growth0.64290.585526904-153884-22.6038
2023-12-31Wasatch Small Cap Value0.59090.450948425000
2024-01-31Fidelity Small Cap Index0.5490.038844992560361.3598
2024-03-28iShares Russell 2000 Value ETF0.48230.0895395301-251-0.0635
2023-12-31Federated Hermes Kaufmann Small Cap Grow0.45760.11863750003750000
2023-12-31Federated Hermes Kaufmann Small Cap A0.45760.11863750003750000
2024-03-28iShares Biotechnology ETF0.45630.13913739748478229.3169
Total 20.0749.871116452230+1340537+8.1%

3.3. Insider Transactions

Insiders are holding 0.946% of the shares of Dyne Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-11Joshua T BrummSELL6638725.67
2024-03-11Wildon FarwellSELL158525.7
2024-03-11Susanna Gatti HighSELL229225.7
2024-03-11Richard William ScalzoSELL267225.28
2024-03-07Joshua T BrummSELL908625.85
2024-03-07Oxana BeskrovnayaSELL237325.85
2024-03-07Richard William ScalzoSELL227325.85
2024-03-07Susanna Gatti HighSELL159125.85
2024-02-29Richard William ScalzoSELL342927.5
2024-02-29Joshua T BrummSELL552027.5
2024-02-29Jonathan McneillSELL426827.5
2024-02-28Venture Fund Xi L.p. AtlasSELL15467424.84
2024-02-28Jason P RhodesSELL19092024.84
2024-02-26Jason P RhodesSELL24821923.72
2024-02-26Venture Fund Xi L.p. AtlasSELL20109523.72
2024-02-23Venture Fund Xi L.p. AtlasSELL15954222.7
2024-02-22Jason P RhodesSELL11936022.66
2024-02-21Venture Fund Xi L.p. AtlasSELL18450122.57
2024-02-20Jason P RhodesSELL16953922.72
2024-02-16Venture Fund Xi L.p. AtlasSELL16270723.14

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Dyne Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.741-0.491-34%-0.353-52%-0.590-20%-0.617-17%
Book Value Per Share--1.1142.111-47%3.434-68%4.272-74%11.363-90%
Current Ratio--2.5327.356-66%11.660-78%18.466-86%10.957-77%
Debt To Asset Ratio--0.4470.261+71%0.158+183%0.182+145%0.451-1%
Debt To Equity Ratio--0.8080.392+106%0.188+331%0.465+74%1.888-57%
Dividend Per Share----0%-0%-0%0.017-100%
Eps---0.813-0.783-4%-0.564-31%-0.454-44%-0.593-27%
Free Cash Flow Per Share---0.428-0.576+35%-0.478+12%-0.356-17%-0.091-79%
Free Cash Flow To Equity Per Share---0.426-0.410-4%-0.364-15%0.085-602%1.743-124%
Gross Profit Margin--0.9910.998-1%1.000-1%1.000-1%1.000-1%
Intrinsic Value_10Y_max--20.987--------
Intrinsic Value_10Y_min---22.487--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---1.978--------
Intrinsic Value_3Y_max--1.590--------
Intrinsic Value_3Y_min---6.217--------
Intrinsic Value_5Y_max--5.123--------
Intrinsic Value_5Y_min---10.723--------
Market Cap2047313238.080+47%1090042676.800922643265.720+18%835972579.200+30%872944786.951+25%462147240.151+136%
Net Profit Margin---17.592-4.398-75%--100%-0.977-94%-0.783-96%
Operating Margin---17.869-4.467-75%--100%-0.993-94%-0.625-97%
Operating Ratio--17.8694.467+300%-+100%0.993+1700%1.482+1106%
Pb Ratio22.426+47%11.9406.282+90%3.060+290%3.291+263%1.742+585%
Pe Ratio-7.681-88%-4.089-3.582-12%-4.718+15%-6.533+60%-3.459-15%
Price Per Share24.980+47%13.30011.258+18%10.200+30%10.651+25%5.639+136%
Price To Free Cash Flow Ratio-14.587-88%-7.766-5.129-34%-5.563-28%-8.024+3%-4.248-45%
Price To Total Gains Ratio-33.703-88%-17.944-37.042+106%74.592-124%-1.906-89%-1.906-89%
Quick Ratio--2.4388.655-72%16.522-85%21.878-89%12.443-80%
Return On Assets---0.404-0.276-32%-0.125-69%-0.162-60%-0.092-77%
Return On Equity---0.730-0.404-45%-0.149-80%-0.206-72%-0.147-80%
Total Gains Per Share---0.741-0.491-34%-0.353-52%-0.590-20%-0.600-19%
Usd Book Value--91292000.000173035500.000-47%281406500.000-68%350094555.556-74%1350755941.176-93%
Usd Book Value Change Per Share---0.741-0.491-34%-0.353-52%-0.590-20%-0.617-17%
Usd Book Value Per Share--1.1142.111-47%3.434-68%4.272-74%11.363-90%
Usd Dividend Per Share----0%-0%-0%0.017-100%
Usd Eps---0.813-0.783-4%-0.564-31%-0.454-44%-0.593-27%
Usd Free Cash Flow---35088000.000-47221750.000+35%-39178000.000+12%-29161388.889-17%-1673676.471-95%
Usd Free Cash Flow Per Share---0.428-0.576+35%-0.478+12%-0.356-17%-0.091-79%
Usd Free Cash Flow To Equity Per Share---0.426-0.410-4%-0.364-15%0.085-602%1.743-124%
Usd Market Cap2047313238.080+47%1090042676.800922643265.720+18%835972579.200+30%872944786.951+25%462147240.151+136%
Usd Price Per Share24.980+47%13.30011.258+18%10.200+30%10.651+25%5.639+136%
Usd Profit---66638000.000-58562000.000-12%-41309250.000-38%-34415944.444-48%-91720205.882+38%
Usd Revenue--3788000.000947000.000+300%-+100%210444.444+1700%259934941.176-99%
Usd Total Gains Per Share---0.741-0.491-34%-0.353-52%-0.590-20%-0.600-19%
 EOD+5 -3MRQTTM+10 -24YOY+8 -265Y+4 -3010Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Dyne Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.681
Price to Book Ratio (EOD)Between0-122.426
Net Profit Margin (MRQ)Greater than0-17.592
Operating Margin (MRQ)Greater than0-17.869
Quick Ratio (MRQ)Greater than12.438
Current Ratio (MRQ)Greater than12.532
Debt to Asset Ratio (MRQ)Less than10.447
Debt to Equity Ratio (MRQ)Less than10.808
Return on Equity (MRQ)Greater than0.15-0.730
Return on Assets (MRQ)Greater than0.05-0.404
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Dyne Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.872
Ma 20Greater thanMa 5026.313
Ma 50Greater thanMa 10025.985
Ma 100Greater thanMa 20021.003
OpenGreater thanClose25.630
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  9,5821,42111,003-8,6802,3238,07010,393-10,3930
Gross Profit  -615-8-623-51-67477-5973,8183,221
Income Tax Expense  -1,317-372-1,689-518-2,2071,776-4314,7584,327



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets165,082
Total Liabilities73,790
Total Stockholder Equity91,292
 As reported
Total Liabilities 73,790
Total Stockholder Equity+ 91,292
Total Assets = 165,082

Assets

Total Assets165,082
Total Current Assets129,375
Long-term Assets35,707
Total Current Assets
Cash And Cash Equivalents 121,626
Short-term Investments 1,474
Other Current Assets 6,275
Total Current Assets  (as reported)129,375
Total Current Assets  (calculated)129,375
+/-0
Long-term Assets
Property Plant Equipment 33,392
Other Assets 0
Long-term Assets  (as reported)35,707
Long-term Assets  (calculated)33,392
+/- 2,315

Liabilities & Shareholders' Equity

Total Current Liabilities51,095
Long-term Liabilities22,695
Total Stockholder Equity91,292
Total Current Liabilities
Short-term Debt 4,720
Accounts payable 22,936
Other Current Liabilities 23,439
Total Current Liabilities  (as reported)51,095
Total Current Liabilities  (calculated)51,095
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt22,695
Long-term Liabilities  (as reported)22,695
Long-term Liabilities  (calculated)22,695
+/-0
Total Stockholder Equity
Common Stock6
Retained Earnings -632,510
Other Stockholders Equity 723,796
Total Stockholder Equity (as reported)91,292
Total Stockholder Equity (calculated)91,292
+/-0
Other
Capital Stock6
Cash and Short Term Investments 123,100
Common Stock Shares Outstanding 61,393
Liabilities and Stockholders Equity 165,082
Net Debt -94,211
Net Invested Capital 91,292
Net Working Capital 78,280
Property Plant and Equipment Gross 38,680
Short Long Term Debt Total 27,415



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-30
> Total Assets 
13,324,000
13,404,000
13,221,000
14,823,000
16,518,000
14,202,000
14,213,000
14,131,000
13,540,000
13,024,000
10,953,000
11,457,000
10,596,000
11,121,000
10,013,000
9,819,000
9,863,000
11,106,000
4,127,000
4,112,000
119,000
5,971,000
4,535,000
4,382,000
4,153,000
4,150,000
5,291,000
5,352,000
5,188,000
5,047,000
11,232,000
11,215,000
12,149,000
12,157,000
11,539,000
11,708,000
13,162,000
13,024,000
13,053,000
13,080,000
12,759,000
12,007,000
11,771,000
0
16,436
0
146,771
381,472
353,334
491,710
467,147
466,878
425,663
387,762
340,026
299,679
306,325
288,642
251,421
205,244
165,082
165,082205,244251,421288,642306,325299,679340,026387,762425,663466,878467,147491,710353,334381,472146,771016,436011,771,00012,007,00012,759,00013,080,00013,053,00013,024,00013,162,00011,708,00011,539,00012,157,00012,149,00011,215,00011,232,0005,047,0005,188,0005,352,0005,291,0004,150,0004,153,0004,382,0004,535,0005,971,000119,0004,112,0004,127,00011,106,0009,863,0009,819,00010,013,00011,121,00010,596,00011,457,00010,953,00013,024,00013,540,00014,131,00014,213,00014,202,00016,518,00014,823,00013,221,00013,404,00013,324,000
   > Total Current Assets 
2,024,000
2,110,000
1,663,000
3,188,000
5,055,000
2,722,000
2,803,000
3,136,000
2,863,000
3,774,000
2,038,000
3,097,000
2,359,000
2,978,000
2,244,000
2,930,000
3,017,000
3,580,000
672,000
742,000
53,000
2,231,000
1,043,000
956,000
913,000
978,000
1,685,000
1,837,000
1,699,000
1,591,000
2,674,000
2,657,000
2,097,000
2,267,000
1,945,000
2,281,000
2,441,000
2,639,000
2,987,000
1,691,000
1,590,000
1,704,000
1,524,000
0
14,759
11,881
145,081
379,840
345,314
487,068
461,297
424,655
382,392
344,450
297,934
258,234
256,012
238,211
213,173
157,823
129,375
129,375157,823213,173238,211256,012258,234297,934344,450382,392424,655461,297487,068345,314379,840145,08111,88114,75901,524,0001,704,0001,590,0001,691,0002,987,0002,639,0002,441,0002,281,0001,945,0002,267,0002,097,0002,657,0002,674,0001,591,0001,699,0001,837,0001,685,000978,000913,000956,0001,043,0002,231,00053,000742,000672,0003,580,0003,017,0002,930,0002,244,0002,978,0002,359,0003,097,0002,038,0003,774,0002,863,0003,136,0002,803,0002,722,0005,055,0003,188,0001,663,0002,110,0002,024,000
       Cash And Cash Equivalents 
323,000
638,000
328,000
429,000
271,000
750,000
693,000
722,000
594,000
703,000
471,000
688,000
282,000
491,000
291,000
328,000
399,000
881,000
396,000
410,000
51,000
677,000
348,000
304,000
461,000
589,000
843,000
996,000
948,000
1,032,000
1,870,000
1,734,000
711,000
934,000
505,000
821,000
1,142,000
1,458,000
1,776,000
467,000
447,000
613,000
365,000
0
14,632
0
144,872
379,606
300,852
310,949
258,385
229,042
200,825
147,965
135,980
144,901
172,147
181,114
167,608
130,279
121,626
121,626130,279167,608181,114172,147144,901135,980147,965200,825229,042258,385310,949300,852379,606144,872014,6320365,000613,000447,000467,0001,776,0001,458,0001,142,000821,000505,000934,000711,0001,734,0001,870,0001,032,000948,000996,000843,000589,000461,000304,000348,000677,00051,000410,000396,000881,000399,000328,000291,000491,000282,000688,000471,000703,000594,000722,000693,000750,000271,000429,000328,000638,000323,000
       Short-term Investments 
86,000
96,000
104,000
113,000
62,000
125,000
87,000
118,000
121,000
115,000
78,000
112,000
219,000
182,000
106,000
76,000
106,000
164,000
69,000
69,000
63,000
563,000
13,000
36,000
8,000
14,000
25,000
18,000
10,000
2,000
78,000
80,000
78,000
69,000
100,000
177,000
64,000
73,000
130,000
129,000
83,000
50,000
32,000
0
0
0
0
0
44,462
172,136
177,204
178,481
175,746
175,185
155,858
103,241
83,865
57,097
40,125
27,544
1,474
1,47427,54440,12557,09783,865103,241155,858175,185175,746178,481177,204172,13644,4620000032,00050,00083,000129,000130,00073,00064,000177,000100,00069,00078,00080,00078,0002,00010,00018,00025,00014,0008,00036,00013,000563,00063,00069,00069,000164,000106,00076,000106,000182,000219,000112,00078,000115,000121,000118,00087,000125,00062,000113,000104,00096,00086,000
       Net Receivables 
431,000
386,000
426,000
383,000
478,000
351,000
340,000
232,000
252,000
253,000
212,000
164,000
198,000
202,000
230,000
179,000
169,000
180,000
6,000
5,000
1,000
131,000
108,000
87,000
106,000
94,000
420,000
409,000
367,000
243,000
270,000
268,000
439,000
436,000
402,000
339,000
392,000
374,000
386,000
394,000
441,000
478,000
513,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000513,000478,000441,000394,000386,000374,000392,000339,000402,000436,000439,000268,000270,000243,000367,000409,000420,00094,000106,00087,000108,000131,0001,0005,0006,000180,000169,000179,000230,000202,000198,000164,000212,000253,000252,000232,000340,000351,000478,000383,000426,000386,000431,000
       Inventory 
193,000
197,000
199,000
185,000
172,000
164,000
184,000
185,000
179,000
157,000
141,000
138,000
136,000
121,000
121,000
130,000
125,000
105,000
57,000
70,000
0
125,000
101,000
93,000
76,000
75,000
181,000
181,000
206,000
186,000
208,000
224,000
523,000
531,000
597,000
579,000
520,000
447,000
445,000
513,000
477,000
429,000
445,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000445,000429,000477,000513,000445,000447,000520,000579,000597,000531,000523,000224,000208,000186,000206,000181,000181,00075,00076,00093,000101,000125,000070,00057,000105,000125,000130,000121,000121,000136,000138,000141,000157,000179,000185,000184,000164,000172,000185,000199,000197,000193,000
       Other Current Assets 
991,000
793,000
606,000
2,078,000
4,072,000
1,332,000
1,499,000
1,879,000
1,717,000
2,546,000
1,136,000
1,995,000
1,524,000
1,982,000
1,496,000
2,217,000
2,218,000
2,250,000
144,000
257,000
-62,000
735,000
473,000
436,000
262,000
206,000
216,000
233,000
168,000
128,000
248,000
351,000
346,000
297,000
341,000
365,000
323,000
287,000
250,000
188,000
142,000
134,000
169,000
0
127
0
209
234
3,773
3,983
25,708
17,132
5,821
21,300
6,096
10,092
9,582
11,003
5,440
10,393
6,275
6,27510,3935,44011,0039,58210,0926,09621,3005,82117,13225,7083,9833,77323420901270169,000134,000142,000188,000250,000287,000323,000365,000341,000297,000346,000351,000248,000128,000168,000233,000216,000206,000262,000436,000473,000735,000-62,000257,000144,0002,250,0002,218,0002,217,0001,496,0001,982,0001,524,0001,995,0001,136,0002,546,0001,717,0001,879,0001,499,0001,332,0004,072,0002,078,000606,000793,000991,000
   > Long-term Assets 
11,300,000
11,294,000
11,558,000
11,635,000
11,463,000
11,480,000
11,410,000
10,995,000
10,677,000
9,250,000
8,915,000
8,360,000
8,237,000
8,143,000
7,769,000
6,889,000
6,846,000
7,526,000
3,455,000
3,370,000
66,000
3,740,000
3,492,000
3,426,000
3,240,000
3,172,000
3,606,000
3,515,000
3,489,000
3,456,000
8,558,000
8,558,000
10,052,000
9,890,000
9,594,000
9,427,000
10,721,000
10,385,000
10,066,000
11,389,000
11,169,000
10,303,000
10,247,000
0
1,676
0
1,690
1,632
8,020
4,642
5,850
42,223
43,271
43,312
42,092
41,445
50,313
50,431
38,248
47,421
35,707
35,70747,42138,24850,43150,31341,44542,09243,31243,27142,2235,8504,6428,0201,6321,69001,676010,247,00010,303,00011,169,00011,389,00010,066,00010,385,00010,721,0009,427,0009,594,0009,890,00010,052,0008,558,0008,558,0003,456,0003,489,0003,515,0003,606,0003,172,0003,240,0003,426,0003,492,0003,740,00066,0003,370,0003,455,0007,526,0006,846,0006,889,0007,769,0008,143,0008,237,0008,360,0008,915,0009,250,00010,677,00010,995,00011,410,00011,480,00011,463,00011,635,00011,558,00011,294,00011,300,000
       Property Plant Equipment 
10,486,000
10,579,000
10,689,000
10,796,000
10,560,000
10,684,000
10,869,000
10,801,000
10,892,000
8,895,000
9,071,000
8,548,000
6,529,000
6,364,000
6,273,000
6,215,000
6,201,000
6,178,000
3,334,000
3,314,000
0
3,270,000
3,022,000
2,988,000
3,006,000
2,969,000
3,315,000
3,262,000
3,260,000
3,223,000
3,255,000
3,227,000
8,666,000
8,485,000
8,347,000
8,242,000
7,588,000
7,252,000
7,121,000
9,719,000
9,485,000
8,929,000
8,884,000
0
1,485
1,499
1,499
1,441
1,946
2,339
2,965
39,915
40,960
40,999
39,777
39,128
38,412
37,107
35,925
34,703
33,392
33,39234,70335,92537,10738,41239,12839,77740,99940,96039,9152,9652,3391,9461,4411,4991,4991,48508,884,0008,929,0009,485,0009,719,0007,121,0007,252,0007,588,0008,242,0008,347,0008,485,0008,666,0003,227,0003,255,0003,223,0003,260,0003,262,0003,315,0002,969,0003,006,0002,988,0003,022,0003,270,00003,314,0003,334,0006,178,0006,201,0006,215,0006,273,0006,364,0006,529,0008,548,0009,071,0008,895,00010,892,00010,801,00010,869,00010,684,00010,560,00010,796,00010,689,00010,579,00010,486,000
       Goodwill 
590,000
532,000
438,000
438,000
438,000
433,000
433,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
837,000
818,000
797,000
797,000
799,000
799,000
799,000
799,000
799,000
772,000
772,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000772,000772,000799,000799,000799,000799,000799,000797,000797,000818,000837,0000000000000000000000000000433,000433,000438,000438,000438,000532,000590,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000136,00000000000000000000
       Intangible Assets 
337,000
321,000
497,000
481,000
465,000
451,000
437,000
438,000
418,000
399,000
380,000
177,000
165,000
153,000
141,000
129,000
116,000
104,000
0
0
0
211,000
271,000
223,000
175,000
127,000
108,000
86,000
60,000
39,000
27,000
25,000
124,000
120,000
102,000
81,000
70,000
54,000
38,000
31,000
23,000
24,000
25,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000025,00024,00023,00031,00038,00054,00070,00081,000102,000120,000124,00025,00027,00039,00060,00086,000108,000127,000175,000223,000271,000211,000000104,000116,000129,000141,000153,000165,000177,000380,000399,000418,000438,000437,000451,000465,000481,000497,000321,000337,000
       Long-term Assets Other 
-113,000
-138,000
-66,000
-80,000
0
-88,000
-329,000
-244,000
-633,000
-44,000
-536,000
-365,000
1,536,000
1,601,000
1,343,000
533,000
517,000
1,240,000
116,000
56,000
66,000
243,000
181,000
119,000
-39,000
-26,000
72,000
84,000
93,000
115,000
5,254,000
5,270,000
345,000
352,000
330,000
255,000
2,238,000
2,240,000
1,665,000
806,000
816,000
529,000
-31,000
0
191
0
191
191
6,074
2,303
2,885
2,308
2,311
2,313
2,315
2,317
9,582
11,003
2,323
10,393
0
010,3932,32311,0039,5822,3172,3152,3132,3112,3082,8852,3036,07419119101910-31,000529,000816,000806,0001,665,0002,240,0002,238,000255,000330,000352,000345,0005,270,0005,254,000115,00093,00084,00072,000-26,000-39,000119,000181,000243,00066,00056,000116,0001,240,000517,000533,0001,343,0001,601,0001,536,000-365,000-536,000-44,000-633,000-244,000-329,000-88,0000-80,000-66,000-138,000-113,000
> Total Liabilities 
9,018,000
8,865,000
8,692,000
10,462,000
12,430,000
9,516,000
9,728,000
9,951,000
9,616,000
9,279,000
7,974,000
8,355,000
7,686,000
8,231,000
7,267,000
7,148,000
7,304,000
8,619,000
3,015,000
3,053,000
121,000
7,121,000
2,032,000
2,019,000
1,937,000
1,862,000
3,081,000
3,182,000
3,137,000
2,997,000
8,209,000
8,379,000
8,827,000
8,975,000
8,618,000
8,799,000
10,694,000
10,813,000
11,011,000
10,654,000
10,636,000
10,018,000
9,870,000
0
2,400
0
14,290
14,627
10,967
13,450
14,551
52,762
57,466
51,303
52,967
49,935
53,961
46,707
44,544
53,206
73,790
73,79053,20644,54446,70753,96149,93552,96751,30357,46652,76214,55113,45010,96714,62714,29002,40009,870,00010,018,00010,636,00010,654,00011,011,00010,813,00010,694,0008,799,0008,618,0008,975,0008,827,0008,379,0008,209,0002,997,0003,137,0003,182,0003,081,0001,862,0001,937,0002,019,0002,032,0007,121,000121,0003,053,0003,015,0008,619,0007,304,0007,148,0007,267,0008,231,0007,686,0008,355,0007,974,0009,279,0009,616,0009,951,0009,728,0009,516,00012,430,00010,462,0008,692,0008,865,0009,018,000
   > Total Current Liabilities 
1,130,000
1,246,000
999,000
2,660,000
4,607,000
1,583,000
1,702,000
1,815,000
1,704,000
1,442,000
1,847,000
1,982,000
1,563,000
2,124,000
1,565,000
2,492,000
2,299,000
6,035,000
159,000
200,000
24,000
867,000
347,000
369,000
317,000
321,000
721,000
827,000
753,000
628,000
681,000
820,000
946,000
1,010,000
812,000
863,000
749,000
911,000
916,000
904,000
903,000
867,000
1,049,000
0
2,358
4,134
4,134
4,678
10,967
13,450
14,551
23,351
28,723
23,237
25,622
23,321
28,088
21,587
20,221
29,692
51,095
51,09529,69220,22121,58728,08823,32125,62223,23728,72323,35114,55113,45010,9674,6784,1344,1342,35801,049,000867,000903,000904,000916,000911,000749,000863,000812,0001,010,000946,000820,000681,000628,000753,000827,000721,000321,000317,000369,000347,000867,00024,000200,000159,0006,035,0002,299,0002,492,0001,565,0002,124,0001,563,0001,982,0001,847,0001,442,0001,704,0001,815,0001,702,0001,583,0004,607,0002,660,000999,0001,246,0001,130,000
       Short-term Debt 
54,000
53,000
51,000
51,000
57,000
57,000
64,000
64,000
93,000
65,000
807,000
63,000
146,000
146,000
148,000
1,153,000
1,008,000
3,357,000
4,000
4,000
0
16,000
29,000
29,000
7,000
7,000
13,000
36,000
37,000
37,000
31,000
8,000
52,000
71,000
83,000
108,000
141,000
167,000
201,000
117,000
106,000
99,000
105,000
0
0
0
0
0
0
596
403
4,589
3,893
4,711
5,489
4,576
4,610
4,644
4,713
4,713
4,720
4,7204,7134,7134,6444,6104,5765,4894,7113,8934,589403596000000105,00099,000106,000117,000201,000167,000141,000108,00083,00071,00052,0008,00031,00037,00037,00036,00013,0007,0007,00029,00029,00016,00004,0004,0003,357,0001,008,0001,153,000148,000146,000146,00063,000807,00065,00093,00064,00064,00057,00057,00051,00051,00053,00054,000
       Accounts payable 
330,000
307,000
292,000
298,000
412,000
323,000
303,000
158,000
191,000
231,000
181,000
124,000
138,000
180,000
134,000
128,000
111,000
166,000
15,000
11,000
0
92,000
112,000
95,000
87,000
81,000
329,000
370,000
305,000
173,000
216,000
248,000
351,000
315,000
292,000
243,000
286,000
263,000
332,000
287,000
370,000
288,000
367,000
0
1,256
2,192
2,192
1,488
3,440
5,760
5,649
7,088
4,031
5,188
6,972
919
5,259
8,770
2,724
3,553
22,936
22,9363,5532,7248,7705,2599196,9725,1884,0317,0885,6495,7603,4401,4882,1922,1921,2560367,000288,000370,000287,000332,000263,000286,000243,000292,000315,000351,000248,000216,000173,000305,000370,000329,00081,00087,00095,000112,00092,000011,00015,000166,000111,000128,000134,000180,000138,000124,000181,000231,000191,000158,000303,000323,000412,000298,000292,000307,000330,000
       Other Current Liabilities 
632,000
864,000
611,000
2,194,000
4,137,000
1,191,000
1,329,000
1,585,000
1,416,000
1,142,000
853,000
1,788,000
1,272,000
1,773,000
1,271,000
1,199,000
1,168,000
2,508,000
135,000
185,000
24,000
759,000
111,000
150,000
128,000
138,000
279,000
342,000
346,000
352,000
414,000
532,000
521,000
570,000
408,000
512,000
322,000
445,000
378,000
465,000
397,000
462,000
570,000
0
1,102
82
1,942
3,190
7,527
7,094
8,499
11,674
20,799
13,338
13,161
17,826
18,219
8,173
12,784
21,426
23,439
23,43921,42612,7848,17318,21917,82613,16113,33820,79911,6748,4997,0947,5273,1901,942821,1020570,000462,000397,000465,000378,000445,000322,000512,000408,000570,000521,000532,000414,000352,000346,000342,000279,000138,000128,000150,000111,000759,00024,000185,000135,0002,508,0001,168,0001,199,0001,271,0001,773,0001,272,0001,788,000853,0001,142,0001,416,0001,585,0001,329,0001,191,0004,137,0002,194,000611,000864,000632,000
   > Long-term Liabilities 
503,000
474,000
439,000
422,000
453,000
417,000
564,000
552,000
567,000
516,000
1,166,000
409,000
5,561,000
5,560,000
5,403,000
4,330,000
4,682,000
2,425,000
734,000
735,000
1,347,000
1,916,000
1,738,000
1,702,000
1,676,000
1,599,000
2,257,000
2,227,000
2,248,000
2,234,000
7,312,000
7,345,000
7,388,000
7,473,000
7,418,000
7,534,000
9,587,000
9,560,000
8,953,000
9,400,000
9,402,000
8,832,000
8,481,000
0
42
0
10,156
9,949
0
7,094
8,499
29,411
28,743
28,066
27,345
26,614
25,873
25,120
24,323
23,514
22,695
22,69523,51424,32325,12025,87326,61427,34528,06628,74329,4118,4997,09409,94910,15604208,481,0008,832,0009,402,0009,400,0008,953,0009,560,0009,587,0007,534,0007,418,0007,473,0007,388,0007,345,0007,312,0002,234,0002,248,0002,227,0002,257,0001,599,0001,676,0001,702,0001,738,0001,916,0001,347,000735,000734,0002,425,0004,682,0004,330,0005,403,0005,560,0005,561,000409,0001,166,000516,000567,000552,000564,000417,000453,000422,000439,000474,000503,000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,656,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,949
9,936
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000009,9369,94900000000000000000000000000001,656,00000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207
207
13
0
0
0
0
0
0
52,967
0
0
0
0
0
0
00000052,96700000013207207000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
613,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000613,00000000000000000000
> Total Stockholder Equity
4,322,000
4,553,000
4,506,000
4,350,000
4,080,000
4,679,000
4,515,000
4,184,000
3,872,000
3,668,000
2,902,000
3,102,000
2,910,000
2,890,000
2,746,000
2,671,000
2,559,000
2,487,000
1,112,000
1,059,000
-2,000
-1,150,000
2,503,000
2,363,000
2,216,000
2,288,000
2,210,000
2,170,000
2,051,000
2,050,000
3,023,000
2,836,000
3,322,000
3,182,000
2,921,000
2,909,000
2,468,000
2,211,000
2,042,000
2,426,000
2,123,000
1,989,000
1,901,000
0
14,036
0
132,481
366,845
342,367
478,260
452,596
414,116
368,197
336,459
287,059
249,744
252,364
241,935
206,877
152,038
91,292
91,292152,038206,877241,935252,364249,744287,059336,459368,197414,116452,596478,260342,367366,845132,481014,03601,901,0001,989,0002,123,0002,426,0002,042,0002,211,0002,468,0002,909,0002,921,0003,182,0003,322,0002,836,0003,023,0002,050,0002,051,0002,170,0002,210,0002,288,0002,216,0002,363,0002,503,000-1,150,000-2,0001,059,0001,112,0002,487,0002,559,0002,671,0002,746,0002,890,0002,910,0003,102,0002,902,0003,668,0003,872,0004,184,0004,515,0004,679,0004,080,0004,350,0004,506,0004,553,0004,322,000
   Common Stock
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
6,000
6,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
0
1
1
3
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6666666666665531101,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0006,0006,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000-3,464,00000000000000000000
   Accumulated Other Comprehensive Income 
-18,000
-16,000
-25,000
-36,000
-42,000
-52,000
-215,000
-212,000
-183,000
-179,000
-150,000
-71,000
-71,000
-70,000
-53,000
-52,000
-51,000
-50,000
-53,000
-50,000
-48,000
-24,000
11,000
11,000
4,000
50,000
58,000
55,000
54,000
53,000
20,000
19,000
14,000
24,000
19,000
18,000
17,000
15,000
21,000
34,000
28,000
26,000
32,000
0
-295
0
0
-778
-27
-68
-41
-34
-269
-930
-1,156
-983
-571
-203
-56
-13
0
0-13-56-203-571-983-1,156-930-269-34-41-68-27-77800-295032,00026,00028,00034,00021,00015,00017,00018,00019,00024,00014,00019,00020,00053,00054,00055,00058,00050,0004,00011,00011,000-24,000-48,000-50,000-53,000-50,000-51,000-52,000-53,000-70,000-71,000-71,000-150,000-179,000-183,000-212,000-215,000-52,000-42,000-36,000-25,000-16,000-18,000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,073,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,493
417,374
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000417,3746,49300000000000000000000000000006,073,00000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000-71,00000000000000000000
   Other Stockholders Equity 
4,335,000
4,564,000
4,526,000
4,381,000
4,117,000
4,726,000
4,725,000
4,391,000
4,050,000
3,842,000
3,046,000
3,167,000
5,989,000
5,991,000
5,994,000
5,995,000
5,998,000
6,000,000
6,005,000
6,007,000
6,008,000
5,159,000
2,598,000
2,600,000
2,605,000
2,609,000
2,614,000
2,618,000
2,623,000
2,628,000
3,738,000
3,732,000
3,835,000
3,709,000
3,587,000
3,586,000
3,947,000
3,941,000
3,947,000
3,721,000
3,720,000
3,720,000
3,719,000
0
6,647
0
169,092
418,152
421,572
582,473
586,737
590,832
596,934
601,440
604,570
608,467
649,502
682,892
712,589
717,917
723,796
723,796717,917712,589682,892649,502608,467604,570601,440596,934590,832586,737582,473421,572418,152169,09206,64703,719,0003,720,0003,720,0003,721,0003,947,0003,941,0003,947,0003,586,0003,587,0003,709,0003,835,0003,732,0003,738,0002,628,0002,623,0002,618,0002,614,0002,609,0002,605,0002,600,0002,598,0005,159,0006,008,0006,007,0006,005,0006,000,0005,998,0005,995,0005,994,0005,991,0005,989,0003,167,0003,046,0003,842,0004,050,0004,391,0004,725,0004,726,0004,117,0004,381,0004,526,0004,564,0004,335,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-2,461
Gross Profit-2,461-2,461
 
Operating Income (+$)
Gross Profit-2,461
Operating Expense-239,701
Operating Income-242,162-242,162
 
Operating Expense (+$)
Research Development210,762
Selling General Administrative31,400
Selling And Marketing Expenses-2,461
Operating Expense239,701239,701
 
Net Interest Income (+$)
Interest Income7,232
Interest Expense-0
Other Finance Cost-0
Net Interest Income7,232
 
Pretax Income (+$)
Operating Income-242,162
Net Interest Income7,232
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-235,937-248,387
EBIT - interestExpense = -242,162
-235,937
-235,937
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-242,162-235,937
Earnings Before Interest and Taxes (EBITDA)-239,701
 
After tax Income (+$)
Income Before Tax-235,937
Tax Provision-0
Net Income From Continuing Ops-208,125-235,937
Net Income-235,937
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses242,162
Total Other Income/Expenses Net6,225-7,232
 

Technical Analysis of Dyne Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dyne Therapeutics Inc. The general trend of Dyne Therapeutics Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dyne Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dyne Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 29.80 < 30.27.

The bearish price targets are: 21.70 > 19.87 > 15.63.

Tweet this
Dyne Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dyne Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dyne Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dyne Therapeutics Inc. The current macd is -0.44310186.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Dyne Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Dyne Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Dyne Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dyne Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartDyne Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dyne Therapeutics Inc. The current adx is 18.98.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Dyne Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dyne Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dyne Therapeutics Inc. The current sar is 27.79.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dyne Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dyne Therapeutics Inc. The current rsi is 45.87. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Dyne Therapeutics Inc Daily Relative Strength Index (RSI) ChartDyne Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dyne Therapeutics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dyne Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dyne Therapeutics Inc Daily Stochastic Oscillator ChartDyne Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dyne Therapeutics Inc. The current cci is -59.58731754.

Dyne Therapeutics Inc Daily Commodity Channel Index (CCI) ChartDyne Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dyne Therapeutics Inc. The current cmo is -11.6612791.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Dyne Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartDyne Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dyne Therapeutics Inc. The current willr is -60.12793177.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dyne Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dyne Therapeutics Inc Daily Williams %R ChartDyne Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dyne Therapeutics Inc.

Dyne Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dyne Therapeutics Inc. The current atr is 1.56512599.

Dyne Therapeutics Inc Daily Average True Range (ATR) ChartDyne Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dyne Therapeutics Inc. The current obv is 44,109,911.

Dyne Therapeutics Inc Daily On-Balance Volume (OBV) ChartDyne Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dyne Therapeutics Inc. The current mfi is 32.54.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Dyne Therapeutics Inc Daily Money Flow Index (MFI) ChartDyne Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dyne Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Dyne Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dyne Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.872
Ma 20Greater thanMa 5026.313
Ma 50Greater thanMa 10025.985
Ma 100Greater thanMa 20021.003
OpenGreater thanClose25.630
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dyne Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Dyne Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dyne Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dyne Therapeutics Inc

I send you an email if I find something interesting about Dyne Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Dyne Therapeutics Inc.

Receive notifications about Dyne Therapeutics Inc in your mailbox!